Lipoprotein (a) in atherosclerotic diseases: from pathophysiology to diagnosis and treatment

S Lampsas, M Xenou, E Oikonomou, P Pantelidis… - Molecules, 2023 - mdpi.com
Lipoprotein (a)(Lp (a)) is a low-density lipoprotein (LDL) cholesterol-like particle bound to
apolipoprotein (a). Increased Lp (a) levels are an independent, heritable causal risk factor …

Vascular adhesion protein-1: Role in human pathology and application as a biomarker

R Pannecoeck, D Serruys, L Benmeridja… - Critical reviews in …, 2015 - Taylor & Francis
Abstract Vascular adhesion protein-1 (VAP-1) is a member of the copper-containing amine
oxidase/semicarbazide-sensitive amine oxidase (AOC/SSAO) enzyme family. SSAO …

Metabolic syndrome screening and nutritional status of patients with psoriasis: a scoping review

NH Mohamed Haris, S Krishnasamy, KY Chin… - Nutrients, 2023 - mdpi.com
Background: Patients with plaque psoriasis have an increased risk of metabolic syndrome.
However, no studies have assessed the nutritional status or screening methods of this …

Lipoprotein (a) and inflammation: a dangerous duet leading to endothelial loss of integrity

M Pirro, V Bianconi, F Paciullo, MR Mannarino… - Pharmacological …, 2017 - Elsevier
Abstract Lipoprotein (a)[Lp (a)] is an enigmatic lipoprotein whose ancestral useful properties
have been gradually obscured by its adverse pro-atherogenic and pro-thrombotic effects …

Flavonoid compounds and their synergistic effects: Promising approaches for the prevention and treatment of psoriasis with emphasis on keratinocytes–A systematic …

A Ebrahimi, M Mehrabi, SS Miraghaee… - International …, 2024 - Elsevier
Psoriasis, a chronic autoimmune skin disorder, causes rapid and excessive skin cell growth
due to immune system dysfunction. Numerous studies have shown that flavonoids have anti …

Evaluation of serum lipid, lipoprotein, and apolipoprotein levels in psoriatic patients: a systematic review and meta-analysis of case-control studies

M Ramezani, E Zavattaro, M Sadeghi - Advances in Dermatology and …, 2019 - termedia.pl
Evaluation of serum lipid, lipoprotein, and apolipoprotein levels in psoriatic patients: a systematic
review and meta-analysis Page 1 Advances in Dermatology and Allergology 6, December / 2019 …

Association between psoriasis and serum apolipoprotein A1 and B: A systematic review and meta-analysis

F Wang, Y Wang, X Kong, J Mu, Z Wang, X Yang, J Ye - Heliyon, 2023 - cell.com
Background Psoriasis has been linked to dyslipidemia. However, the magnitude of the
association between psoriasis and serum apolipoproteins A1 and B remains unclear …

Methylentetrahydrofolatereductase (rs1801133) polymorphism and psoriasis: contribution to oxidative stress, lipid peroxidation and correlation with vascular adhesion …

M Asefi, A Vaisi‐Raygani, R Khodarahmi… - Journal of the …, 2014 - Wiley Online Library
Background Psoriatic patients are at greater risk of oxidative stress and inflammation which
is associated with abnormal plasma lipid metabolism and lipid peroxidation. There is not any …

Lessons to be learned from serum biomarkers in psoriasis and IBD–the potential role in SpA

MC Turina, R Landewé, D Baeten - Expert review of clinical …, 2017 - Taylor & Francis
Introduction: Early diagnosis, monitoring of disease activity, prediction of treatment
response, and structural outcome remain major challenges in spondyloarthritis (SpA) …

Psoriasis and vascular risk: an update

N Katsiki, P Anagnostis, VG Athyros… - Current …, 2014 - ingentaconnect.com
Psoriasis is a chronic systemic inflammatory disease characterized by topical skin lesions as
well as an increased risk for cardiovascular disease (CVD). There is also increasing …